Black Garlic Supplementation and Glomerular Protection in Hyperuricemic Rats: A Study on Kidney Health Prevention
Abstract
Introduction: Hyperuricemia is a significant risk factor for the development of chronic kidney disease. Excessive uric acid can deposit in the kidneys, triggering inflammatory reactions and oxidative stress, leading to structural damage in the glomeruli. Black garlic, with its antioxidant and bioactive compounds, has the potential to protect the kidneys from hyperuricemia-induced damage. Our objective is to evaluate the effect of black garlic supplementation on the histopathological features of glomeruli in a hyperuricemic rat model.
Methods: This study was an analytical observational study using Biological Remnant Materials (BRM) from a previous study. The sample consisted of 30 male Sprague-Dawley rats divided into 5 groups: disease control, drug control (allopurinol), and 3 black garlic dose groups (240 mg/day, 480 mg/day, and 960 mg/day). Data were collected through histopathological examination of kidney tissue using the glomerular damage scoring method (0-3). Data analysis was performed using one-way ANOVA and post hoc LSD tests.
Results: Black garlic demonstrated protective effects on the histopathological features of glomeruli in hyperuricemic rats. The 240 mg/day dose showed the most significant improvement in kidney health, reducing glomerular damage scores compared to the disease control group (p < 0.05). These findings suggest that black garlic can serve as a preventive agent against kidney complications caused by hyperuricemia.
Conclusion: Black garlic provides protective effects on glomerular histopathology in hyperuricemic rats, with the 240 mg/day dose being the most effective. These results suggest potential use for black garlic in preventing kidney complications in hyperuricemia.
References
Courville K, Bustamante N, Hurtado B, Pecchio M, Rodríguez C, Núñez-Samudio V, et al. Chronic kidney disease of nontraditional causes in central Panama. BMC Nephrol [Internet]. 2022;23(1):275. Available from: https://doi.org/10.1186/s12882-022-02907-3
Jung SW, Kim SM, Kim YG, Lee SH, Moon JY. Uric acid and inflammation in kidney disease. Am J Physiol Renal Physiol. 2020 Jun;318(6):F1327–40.
El-Tantawy WH. Natural products for the management of hyperuricaemia and gout: a review. Arch Physiol Biochem. 2021 Feb;127(1):61–72.
Moreno-Ortega A, Pereira-Caro G, Ordóñez JL, Moreno-Rojas R, Ortíz-Somovilla V, Moreno-Rojas JM. Bioaccessibility of Bioactive Compounds of ‘Fresh Garlic’ and ‘Black Garlic’ through In Vitro Gastrointestinal Digestion. Foods [Internet]. 2020;9(11). Available from: https://www.mdpi.com/2304-8158/9/11/1582
Vinayagam R, Eun Lee K, Ambati RR, Gundamaraju R, Fawzy Ramadan M, Gu Kang S. Recent development in black garlic: Nutraceutical applications and health-promoting phytoconstituents. Food Rev Int [Internet]. 2023 Aug 18;39(6):3534–54. Available from: https://doi.org/10.1080/87559129.2021.2012797
Kovesdy CP. Epidemiology of chronic kidney disease: an update 2022. Kidney Int Suppl. 2022 Apr;12(1):7–11.
Li L, Zhang Y, Zeng C. Update on the epidemiology, genetics, and therapeutic options of hyperuricemia. Am J Transl Res. 2020;12(7):3167–81.
Global, regional, and national burden of chronic kidney disease, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet (London, England). 2020 Feb;395(10225):709–33.
Ameh OI, Ekrikpo UE, Kengne AP. Preventing CKD in Low- and Middle-Income Countries: A Call for Urgent Action. Kidney Int Reports [Internet]. 2020;5(3):255–62. Available from: https://www.sciencedirect.com/science/article/pii/S2468024919316006
Nishizawa H, Maeda N, Shimomura I. Impact of hyperuricemia on chronic kidney disease and atherosclerotic cardiovascular disease. Hypertens Res [Internet]. 2022;45(4):635–40. Available from: https://doi.org/10.1038/s41440-021-00840-w
Wang M, Lin X, Yang X, Yang Y. Research progress on related mechanisms of uric acid activating NLRP3 inflammasome in chronic kidney disease. Ren Fail [Internet]. 2022 Dec 31;44(1):615–24. Available from: https://doi.org/10.1080/0886022X.2022.2036620
Ponticelli C, Podestà MA, Moroni G. Hyperuricemia as a trigger of immune response in hypertension and chronic kidney disease. Kidney Int [Internet]. 2020;98(5):1149–59. Available from: https://www.sciencedirect.com/science/article/pii/S0085253820308048
Ramos GK, Goldfarb DS. Update on Uric Acid and the Kidney. Curr Rheumatol Rep [Internet]. 2022;24(5):132–8. Available from: https://doi.org/10.1007/s11926-022-01069-3
Skoczy?ska M, Chowaniec M, Szymczak A, Langner-Hetma?czuk A, Maci??ek-Chyra B, Wiland P. Pathophysiology of hyperuricemia and its clinical significance - a narrative review. Reumatologia. 2020;58(5):312–23.
Barman Z, Hasan M, Miah R, Mou AD, Hafsa JM, Trisha A Das, et al. Association between hyperuricemia and chronic kidney disease: a cross-sectional study in Bangladeshi adults. BMC Endocr Disord. 2023 Feb;23(1):45.
Halimulati M, Wang R, Aihemaitijiang S, Huang X, Ye C, Zhang Z, et al. Anti-Hyperuricemic Effect of Anserine Based on the Gut-Kidney Axis: Integrated Analysis of Metagenomics and Metabolomics. Nutrients. 2023 Feb;15(4).
Lestari AR, Batubara I, Wahyudi ST, Ilmiawati A, Achmadi SS. Bioactive Compounds in Garlic (Allium sativum) and Black Garlic as Antigout Agents, Using Computer Simulation. Life (Basel, Switzerland). 2022 Jul;12(8).
Ahmed T, Wang CK. Black Garlic and Its Bioactive Compounds on Human Health Diseases: A Review. Molecules. 2021 Aug;26(16).
Brosnahan GM, You Z, Wang W, Gitomer BY, Chonchol M. Serum Uric Acid and Progression of Autosomal Dominant Polycystic Kidney Disease: Results from the HALT PKD Trials. Curr Hypertens Rev. 2021;17(3):228–37.
Mogawer ES, Hegab MM, Elshahaly M, Ragab G. Chapter 10 - Gout: The role of diet, functional foods, and the microbiome and their interplay prevalent in North America and globally. In: Aliani M, Eskin MNABTFF and CD, editors. Academic Press; 2024. p. 153–74. Available from: https://www.sciencedirect.com/science/article/pii/B978032391747600010X
Hemnani RR, Sood S V, Gupta SD, Malhotra SD. Allopurinol-induced hypersensitivity reaction in a patient of underlying renal impairment. Natl J Pharmacol Ther [Internet]. 2024;2(1). Available from: https://journals.lww.com/njpt/fulltext/2024/02010/allopurinol_induced_hypersensitivity_reaction_in_a.11.aspx
Vatsa E, Aggarwal M. Therapeutic Properties of Herbal Constituents Subjected for Clinical Trials BT - Bioprospecting of Tropical Medicinal Plants. In: Arunachalam K, Yang X, Puthanpura Sasidharan S, editors. Cham: Springer Nature Switzerland; 2023. p. 1495–514. Available from: https://doi.org/10.1007/978-3-031-28780-0_63
Murray I V, Paolini MA. Histology, Kidney and Glomerulus [Internet]. StatPearls Publishing, Treasure Island (FL); 2023. Available from: http://europepmc.org/books/NBK554544
Santos MLC, de Brito BB, da Silva FAF, Botelho ACDS, de Melo FF. Nephrotoxicity in cancer treatment: An overview. World J Clin Oncol. 2020 Apr;11(4):190–204.
Ma K, Gao W, Xu H, Liang W, Ma G, Anand V. Role and Mechanism of the Renin-Angiotensin-Aldosterone System in the Onset and Development of Cardiorenal Syndrome. J Renin-Angiotensin-Aldosterone Syst [Internet]. 2022 Jan 1;2022:3239057. Available from: https://doi.org/10.1155/2022/3239057
Varade S, Nadella M, Hirake A, Mungase S bhausaheb, Ali A, Adela R. Effect of garlic on the components of metabolic syndrome: A systematic review and meta-analysis of randomized controlled trials. J Ethnopharmacol [Internet]. 2024;318:116960. Available from: https://www.sciencedirect.com/science/article/pii/S0378874123008280
Ozdemir A, Y?lmaz M, Ozagari AA, Kocak SY. Prognostic value of histopathological scoring and grading in patients with renal AA amyloidosis. Int Urol Nephrol. 2022 Oct;54(10):2591–7.
Liu J, Li J, Ge S, Fu X, Zhu J, Wang M, et al. Characterization of a short-term processing technology of black garlic with low 5-HMF content. Food Control [Internet]. 2024;165:110650. Available from: https://www.sciencedirect.com/science/article/pii/S0956713524003670
Stamp LK, Chapman PT, Palmer SC. Allopurinol and kidney function: An update. Jt bone spine. 2016 Jan;83(1):19–24.
Sharma H, Sapkota HP, Dangi NB. A Brief Review of Analytical Methods for the Estimation of Allopurinol in Pharmaceutical Formulation and Biological Matrices. Int J Anal Chem. 2021;2021:5558651.
Kannangara DRW, Roberts DM, Furlong TJ, Graham GG, Williams KM, Day RO. Oxypurinol, allopurinol and allopurinol-1-riboside in plasma following an acute overdose of allopurinol in a patient with advanced chronic kidney disease. Vol. 73, British journal of clinical pharmacology. England; 2012. p. 828–9.
Rahmah, N. F., Mukaddas, A., & Safarudin S. PROFIL PENGGUNAAN OBAT PADA PASIEN GOUT DAN HIPERURISEMIA DI RSU ANUTAPURA PALU. J Farm Galen (Galenika J Pharmacy). 2016;2(2):118–23.
Cascajosa-Lira A, Andreo-Martínez P, Prieto AI, Baños A, Guillamón E, Jos A, et al. In Vitro Toxicity Studies of Bioactive Organosulfur Compounds from Allium spp. with Potential Application in the Agri-Food Industry: A Review. Foods (Basel, Switzerland). 2022 Aug;11(17).
Villanueva C, Kross RD. Antioxidant-induced stress. Int J Mol Sci. 2012;13(2):2091–109.
Pérez-Torres I, Guarner-Lans V, Rubio-Ruiz ME. Reductive Stress in Inflammation-Associated Diseases and the Pro-Oxidant Effect of Antioxidant Agents. Int J Mol Sci [Internet]. 2017;18(10). Available from: https://www.mdpi.com/1422-0067/18/10/2098
He L, He T, Farrar S, Ji L, Liu T, Ma X. Antioxidants Maintain Cellular Redox Homeostasis by Elimination of Reactive Oxygen Species. Cell Physiol Biochem [Internet]. 2017 Nov 17;44(2):532–53. Available from: https://doi.org/10.1159/000485089
Akbar M, Essa MM, Daradkeh G, Abdelmegeed MA, Choi Y, Mahmood L, et al. Mitochondrial dysfunction and cell death in neurodegenerative diseases through nitroxidative stress. Brain Res [Internet]. 2016;1637:34–55. Available from: https://www.sciencedirect.com/science/article/pii/S0006899316300592
Copyright (c) 2024 Journal of Public Health and Pharmacy
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
Authors who publish with Journal of Public Health and Pharmacy retain the copyright of their work. The journal applies a Creative Commons Attribution-ShareAlike 4.0 International License (CC BY-SA 4.0), which grants the following rights:
-
Copyright Retention: Authors retain the copyright of their work, maintaining full control over their intellectual property without restrictions.
-
Right of First Publication: Authors grant the journal the right of first publication of their work. This ensures that the work is initially published and credited in Journal of Public Health and Pharmacy.
-
License to Share and Reuse: The work is licensed under CC BY-SA 4.0, allowing others to copy, distribute, remix, and build upon the work for any purpose, even commercially, as long as proper credit is given to the authors, and any new creations are licensed under the same terms.
